Published in Steroids on December 08, 2011
New insights into insulin: The anti-inflammatory effect and its clinical relevance. World J Diabetes (2014) 0.94
Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth. Int J Reprod Med (2014) 0.90
Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome. Endocrine (2012) 0.82
Adipocyte dysfunction in a mouse model of polycystic ovary syndrome (PCOS): evidence of adipocyte hypertrophy and tissue-specific inflammation. PLoS One (2012) 0.81
Effect of maternal PCOS and PCOS-like phenotype on the offspring's health. Mol Cell Endocrinol (2015) 0.78
Gestational Hyperandrogenism in Developmental Programming. Endocrinology (2016) 0.78
Effects of jnk inhibitor on inflammation and fibrosis in the ovary tissue of a rat model of polycystic ovary syndrome. Int J Clin Exp Pathol (2015) 0.77
Enhanced Inflammatory Transcriptome in the Granulosa Cells of Women With Polycystic Ovarian Syndrome. J Clin Endocrinol Metab (2016) 0.77
Genetic variation in the Mcp-1 gene promoter associated with the risk of polycystic ovary syndrome. PLoS One (2015) 0.77
Association of TNF-alpha, IL-6 and IL-1beta gene polymorphisms with polycystic ovary syndrome: a meta-analysis. BMC Genet (2015) 0.76
Roles of Oxidative Stress in Polycystic Ovary Syndrome and Cancers. Oxid Med Cell Longev (2015) 0.75
Pioglitazone counteracts the tumor necrosis factor-α inhibition of follicle-stimulating hormone-induced follicular development and estradiol production in an in vitro mouse preantral follicle culture system. J Ovarian Res (2013) 0.75
Anti-Inflammatory Dietary Combo in Overweight and Obese Women with Polycystic Ovary Syndrome. N Am J Med Sci (2015) 0.75
Physical Properties of Blood Are Altered in Young and Lean Women with Polycystic Ovary Syndrome. PLoS One (2016) 0.75
Dual effects of testosterone in Behcet's disease: implications for a role in disease pathogenesis. Genes Immun (2016) 0.75
Beneficial effects of pioglitazone and metformin in murine model of polycystic ovaries via improvement of chemerin gene up-regulation. Daru (2014) 0.75
Follicular fluid soluble receptor for advanced glycation endproducts (sRAGE): a potential protective role in polycystic ovary syndrome. J Assist Reprod Genet (2016) 0.75
Altered Circulating Inflammatory Cytokines Are Associated with Anovulatory Polycystic Ovary Syndrome (PCOS) Women Resistant to Clomiphene Citrate Treatment. Med Sci Monit (2017) 0.75
Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest (2003) 41.22
Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med (1997) 14.51
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril (2004) 12.87
C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation (2003) 6.99
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril (2008) 5.31
Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity (1997) 4.19
Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation (2003) 3.73
Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J Clin Invest (2001) 3.41
C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation (2001) 2.66
Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab (2010) 2.48
The respiratory burst oxidase. J Biol Chem (1994) 2.29
Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril (2010) 2.25
Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab (1998) 2.12
The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes. Biochem Biophys Res Commun (1988) 1.76
Transcriptional repression of the C/EBP-alpha and GLUT4 genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. Regulations is coordinate and independent of protein synthesis. J Biol Chem (1992) 1.56
Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab (2005) 1.52
Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. J Clin Endocrinol Metab (2007) 1.43
Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling. Am J Physiol Endocrinol Metab (2004) 1.33
Increased activation of nuclear factor kappaB triggers inflammation and insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metab (2006) 1.33
Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease. J Clin Endocrinol Metab (2004) 1.30
Genetic demonstration of p47phox-dependent superoxide anion production in murine vascular smooth muscle cells. Circulation (2001) 1.28
TNFalpha release by the nonfat cells of human adipose tissue. Int J Obes Relat Metab Disord (2004) 1.26
Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice. Diabetologia (2008) 1.25
High sensitivity C-reactive protein as a disease activity marker in rheumatoid arthritis. J Rheumatol (2004) 1.22
Hyperglycemia alters tumor necrosis factor-alpha release from mononuclear cells in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2005) 1.22
Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation. J Clin Endocrinol Metab (2004) 1.19
In vitro evidence that hyperglycemia stimulates tumor necrosis factor-alpha release in obese women with polycystic ovary syndrome. J Endocrinol (2006) 1.17
Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome. Metabolism (1999) 1.15
The effects of androgens on the regulation of lipolysis in adipose precursor cells. Endocrinology (1990) 1.09
Evidence of proatherogenic inflammation in polycystic ovary syndrome. Metabolism (2009) 1.08
Ovarian hyperandrogenism in adult female rhesus monkeys exposed to prenatal androgen excess. Fertil Steril (2002) 1.06
The importance of insulin resistance in polycystic ovary syndrome. Fertil Steril (2003) 1.05
The biology of the monocyte system. Eur J Cell Biol (1989) 1.04
The -597 G-->A and -174 G-->C polymorphisms in the promoter of the IL-6 gene are associated with hyperandrogenism. J Clin Endocrinol Metab (2002) 1.02
Association of polymorphisms in the interleukin 6 receptor complex with obesity and hyperandrogenism. Obes Res (2003) 1.01
Prolonged interleukin-6 administration enhances glucose tolerance and increases skeletal muscle PPARalpha and UCP2 expression in rats. J Endocrinol (2008) 1.00
Localization and characterization of white blood cell populations within the human ovary throughout the menstrual cycle and menopause. Hum Reprod (1996) 1.00
Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes. Am J Physiol (1993) 0.99
Hyperandrogenism sensitizes mononuclear cells to promote glucose-induced inflammation in lean reproductive-age women. Am J Physiol Endocrinol Metab (2011) 0.98
Tumor necrosis factor-alpha stimulates proliferation of rat ovarian theca-interstitial cells. Biol Reprod (1999) 0.98
Comment: the methionine 196 arginine polymorphism in exon 6 of the TNF receptor 2 gene (TNFRSF1B) is associated with the polycystic ovary syndrome and hyperandrogenism. J Clin Endocrinol Metab (2002) 0.96
Serum markers of periodontal disease status and inflammation in hemodialysis patients. Am J Kidney Dis (2002) 0.95
Divergent effects of weight reduction and oral anticonception treatment on adrenergic lipolysis regulation in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab (1999) 0.87
C-reactive protein (CRP) levels in systemic lupus erythematosus (SLE). Clin Rheumatol (1986) 0.86
No difference in markers of adipose tissue inflammation between overweight women with polycystic ovary syndrome and weight-matched controls. Hum Reprod (2011) 0.86